Description

Erlonat 150mg (Erlotinib) – Effective Targeted Therapy for Non-Small Cell Lung Cancer and Pancreatic Cancer

Erlonat 150mg is a prescription targeted anticancer medicine formulated with Erlotinib 150mg, an active ingredient widely used for the treatment of specific types of non-small cell lung cancer (NSCLC) and pancreatic cancer. Erlotinib belongs to the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) class of medicines. It works by blocking EGFR signaling, helping slow the growth and spread of cancer cells.

Erlonat 150mg is commonly prescribed for patients with EGFR mutation-positive metastatic non-small cell lung cancer and, in combination with gemcitabine, for locally advanced, unresectable, or metastatic pancreatic cancer. Treatment should always be initiated and monitored by a qualified oncologist, as the appropriate dose depends on the patient’s diagnosis, overall health, liver function, and treatment response.

• Key Features

1. Contains Erlotinib 150mg per tablet
2. Prescription-only targeted anticancer medication
3. Oral tablet for convenient once-daily administration
4. EGFR tyrosine kinase inhibitor (TKI)
5. Used for EGFR mutation-positive non-small cell lung cancer and pancreatic cancer
6. Manufactured under quality pharmaceutical standards

How to Take Erlonat 150mg

For the best therapeutic effect, take Erlonat 150mg exactly as directed by your healthcare provider. Swallow the tablet whole with a glass of water.

It is generally recommended to take Erlonat on an empty stomach, at least 1 hour before or 2 hours after food. Take the medicine at the same time each day. Do not crush, chew, or split the tablet unless advised by your doctor.

Avoid changing the dose or stopping treatment without consulting your healthcare provider.

• General Dosage Reference

Medical Condition	Recommended Adult Dose
EGFR Mutation-Positive Non-Small Cell Lung Cancer (NSCLC)	150mg orally once daily
Pancreatic Cancer (with Gemcitabine)	100mg orally once daily or as prescribed
Other Approved Indications	As directed by the treating oncologist

The exact dosage should always be determined by your healthcare provider based on the type of cancer, liver function, concurrent medications, and individual clinical response.

Safety Information

Before starting Erlonat 150mg, inform your healthcare provider if you have liver disease, kidney disease, lung disease, stomach ulcers, bleeding disorders, eye disorders, or any known allergy to Erlotinib.

Women who are pregnant, planning pregnancy, or breastfeeding should consult their doctor before using this medicine. Erlotinib may harm an unborn baby. Effective contraception is recommended during treatment and for the period advised after the final dose.

Tell your healthcare provider about all prescription medicines, over-the-counter drugs, vitamins, herbal supplements, and smoking habits, as smoking may reduce Erlotinib’s effectiveness and certain medicines may interact with treatment.

Most patients tolerate Erlonat 150mg when taken as prescribed. However, some individuals may experience:

1. Skin rash
2. Diarrhea
3. Fatigue
4. Nausea
5. Loss of appetite
6. Dry skin
7. Mouth sores
8. Eye irritation
9. Elevated liver enzymes

Seek immediate medical attention if you experience severe breathing problems, persistent diarrhea, severe skin reactions, chest pain, eye pain or vision changes, signs of liver problems, or severe allergic reactions.

Product Specifications

Specification	Information
Brand	Erlonat
Generic Name	Erlotinib
Active Ingredient	Erlotinib Hydrochloride
Strength	150mg
Dosage Form	Oral Tablet
Drug Class	EGFR Tyrosine Kinase Inhibitor (TKI)
Route of Administration	Oral
Prescription Status	Prescription Required
Storage	Store below 25°C in a cool, dry place away from moisture and direct sunlight.

Frequently Asked Questions

Can Erlonat 150mg be taken with food?

No. Erlonat 150mg should generally be taken on an empty stomach, at least 1 hour before or 2 hours after meals, unless your healthcare provider advises otherwise.

How quickly does Erlonat 150mg start working?

Erlotinib begins blocking EGFR activity soon after absorption. The time to clinical improvement varies depending on the cancer type, disease stage, and individual response to treatment.

Is Erlonat 150mg chemotherapy?

No. Erlonat 150mg is a targeted therapy (EGFR tyrosine kinase inhibitor) and is different from traditional chemotherapy.

Can I purchase Erlonat 150mg online?

Availability depends on your country’s regulations. A valid prescription may be required before purchasing Erlonat 150mg online.

What should I do if I miss a dose?

Take the missed dose as soon as you remember if it is not close to your next scheduled dose. If it is nearly time for your next dose, skip the missed dose and continue your regular schedule. Do not take two doses together. Consult your healthcare provider if you are unsure.